A complete index of the Tiny Tribes material — public pages with deep links to every chapter and section, plus the reference glossary. Click any URL to jump straight there.
Each tailored to a specific audience — internal team, consumer, and a shared reference library.
| Page | URL | Description |
|---|---|---|
Strategic Brand Book |
tinytribes.eu/ | The internal brand document — nine chapters covering strategy, the name, product architecture, the rotation rationale, ingredient strategy, competitive landscape, marketing angles, and brand identity. |
Consumer Demo Site |
tinytribes.eu/consumer | The consumer-facing prototype site — theme switch (Editorial / Commercial), full-width hero, product pages, FAQ, and waitlist form. Demo only — no real conversion wired up. |
Glossary |
tinytribes.eu/glossary | Plain-English definitions for 40+ terms across Microbiome Science, Ingredients, Regulatory, Business & Funding, and Brand Concepts. Powers the inline tooltips across every other page. |
The brand book is a single page with sidebar navigation. The links below open the document directly on the chosen chapter.
| Chapter | URL | Description |
|---|---|---|
01Overview |
/#overview | Hero page with the three pitch cards (Investor / Consumer / Honest Frame), the four pillars, and the table-of-contents overview. |
02Who / Why / How |
/#approach | Three personas, four-part thesis, five-stage closed loop (Test → Protocol → App → Product → Re-test), partner network, and an honest read on competitive moats. |
03The Name |
/#naming | Why "Tiny Tribes" — bacterial communities as textbook microbiome terminology, plus a direct treatment of the Tiny Health adjacency. |
04Product Architecture |
/#product | Three subscription tiers — Foundation (€79), Complete (€89), Intelligence (€119, 2027 beta). The synbiotic explainer plus 24 unique strains across the 4-phase rotation. |
05Why We Rotate |
/#rotation | The scientific case for sequenced delivery — Zmora 2018 competitive exclusion findings, why 24 strains across 4 phases outperforms 24 strains at once, and what each phase actually does. |
06Ingredient Strategy |
/#prebiotic | The four-phase journey: Foundation (Arabinoxylan), Mediterranean (Olive Pomace), Blueprint (HMOs), Origin (Multi-Mushroom). Includes the premortem table. |
07Competitive |
/#competitive | 28 competitor cards across Tier 1 EU, Tier 1 Global, Tier 2 EU regional, and Tier 3 indirect — plus the quick-reference matrix. |
08Marketing |
/#marketing | Six campaign angles including the GLP-1 companion positioning, the "root cause" angle, and the Mediterranean voice. |
09Brand |
/#brand | Wordmark treatment, colour palette (bone, moss, amber, rust), typography (Fraunces, Outfit, DM Mono), six brand principles, and voice rules. |
The consumer demo is a long-scroll page. These links scroll straight to the requested section.
| Section | URL | Description |
|---|---|---|
Hero & Trust Bar |
/consumer | Full-width hero with floating bacteria icons, the main headline, primary CTA, and partner trust badges (InnerBuddies, Novonesis, Maastricht). |
What's a Synbiotic? |
/consumer#what-is-synbiotic | Plain-English explainer of the synbiotic concept — three labelled pills showing the Pre / Pro / Post layers, with a caption tying them to the 4-phase rotation. |
Problem · How it works |
/consumer#science | "Your gut is running last year's protocol" — the 5-stage closed loop and the 4-phase journey with bacterial cohorts. |
Product Tiers |
/consumer#product | Foundation, Complete (Most Popular), and Intelligence tier cards — features, prices, and the new "Beta · 2027" badge on Intelligence. |
Dark Band Section |
/consumer#product | "100 trillion bacteria call your gut home" — full-width dark moss-green section with floating bacterial icons. |
Pricing |
/consumer#pricing | Pricing summary plus the competitive table (Tiny Tribes vs ZOE, Seed, OMNi-BiOTiC) including the strain delivery model row. |
FAQ |
/consumer#faq | Six frequently asked questions in an accordion with smooth animations, including the competitive-exclusion science answer in the first question. |
Strategic planning documents kept in the git repository. Not reachable via the web; available to team members and privileged investor conversations only.
| Document | Path | Description |
|---|---|---|
Executive Summary |
context/rnd/00-executive-summary.md | Headline figures in one page — capital trajectory, team size, scientists, cap table, 36-month burn. |
Team & Hiring |
context/rnd/01-team-and-hiring.md | Every role, when to hire, salary bands, equity allocation. Headcount trajectory 4 → 11 → 26 FTE. |
Scientific Architecture |
context/rnd/02-scientific-architecture.md | CSO co-founder profile, Academic Advisory Board composition, clinical study roadmap, IP and strain licensing strategy. |
Partner Network |
context/rnd/03-partner-network.md | Every partner (Novonesis, InnerBuddies, Maastricht, EU CMO, etc.) — status, contract type, cost, risk. |
Phased Budget |
context/rnd/04-phased-budget.md | Line-by-line budget per phase (€600K pre-seed, €3M seed, €10M Series A) = €13.6M raised across 36 months. |
Cap Table |
context/rnd/05-cap-table.md | Recommended equity structure: Founder 55% / CSO 10% / Angels 17% / ESOP 15% / Advisors 3%. SAFE template recommendation. |
Risk Register |
context/rnd/06-risk-register.md | 12 risks with severity rating and mitigation — from "CSO doesn't materialise" to "ZOE launches a probiotic". |
Naming Archive |
context/naming-rejected-candidates.md | The seven candidate names considered (Microis, Inner Tribes, Microtribes, Gut Tribes, Flōra, BiomeBase, Tiny Tribes) and why each was selected or rejected. |
Chat Export |
context/microis-chat-export.md | The original strategic conversation in which the brand was built. Historical document; uses the original "Microis" codename throughout. |